Contact this trialFirst, we need to learn more about you.
Opioid Antagonist
Naltrexone + Ecological Momentary Intervention for Methamphetamine Addiction
Recruiting0 awardsPhase 2
San Francisco, California
This trial tests a treatment combining as-needed naltrexone with a real-time reminder system. It targets MSM who use meth due to their high risk of HIV and lack of effective treatments. Naltrexone reduces cravings and meth's effects, while reminders help ensure timely medication use. Naltrexone has been used for opioid dependence and has shown effectiveness in reducing cravings and preventing relapse.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service